These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 36873531

  • 1. Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.
    Wu Y, Xu Y, He S, Li Y, Feng N, Fan J, Gong Y, Li X, Zhou L.
    Heliyon; 2023 Mar; 9(3):e13707. PubMed ID: 36873531
    [Abstract] [Full Text] [Related]

  • 2. Integrating single-cell transcriptomics to reveal the ferroptosis regulators in the tumor microenvironment that contribute to bladder urothelial carcinoma progression and immunotherapy.
    Chen Z, Hu J, Ou Y, Ye F, Li W, Liu S, Jiang H.
    Front Immunol; 2024 Mar; 15():1427124. PubMed ID: 39238647
    [Abstract] [Full Text] [Related]

  • 3. Dysregulation of tumor microenvironment promotes malignant progression and predicts risk of metastasis in bladder cancer.
    Liu J, Zheng Z, Zhang W, Wan M, Ma W, Wang R, Yan Y, Guo Y, Zhang J, Li W, Yao X.
    Ann Transl Med; 2021 Sep; 9(18):1438. PubMed ID: 34733990
    [Abstract] [Full Text] [Related]

  • 4. Long noncoding RNA CYTOR in cancer: A TCGA data review.
    Liang J, Wei X, Liu Z, Cao D, Tang Y, Zou Z, Zhou C, Lu Y.
    Clin Chim Acta; 2018 Aug; 483():227-233. PubMed ID: 29750962
    [Abstract] [Full Text] [Related]

  • 5. Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.
    Xu Y, Sun X, Liu G, Li H, Yu M, Zhu Y.
    Front Immunol; 2023 Aug; 14():1301157. PubMed ID: 38299148
    [Abstract] [Full Text] [Related]

  • 6. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L, Fang H, Guo F, Yin M, Long H, Weng G.
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [Abstract] [Full Text] [Related]

  • 7. lncRNA-CYTOR Works as an Oncogene Through the CYTOR/miR-3679-5p/MACC1 Axis in Colorectal Cancer.
    Li M, Wang Q, Xue F, Wu Y.
    DNA Cell Biol; 2019 Jun; 38(6):572-582. PubMed ID: 31144988
    [Abstract] [Full Text] [Related]

  • 8. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
    Sun X, Xin S, Jin L, Zhang Y, Ye L.
    Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
    [Abstract] [Full Text] [Related]

  • 9. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer.
    Zhang J, Zhou Q, Xie K, Cheng L, Peng S, Xie R, Liu L, Zhang Y, Dong W, Han J, Huang M, Chen Y, Lin T, Huang J, Chen X.
    J Exp Clin Cancer Res; 2021 Jun 21; 40(1):203. PubMed ID: 34154613
    [Abstract] [Full Text] [Related]

  • 10. Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer.
    Wang Y, Chen L, Yu M, Fang Y, Qian K, Wang G, Ju L, Xiao Y, Wang X.
    Cancer Med; 2020 Oct 21; 9(20):7729-7741. PubMed ID: 32841548
    [Abstract] [Full Text] [Related]

  • 11. Androgen Receptor Transcriptionally Inhibits Programmed Death Ligand-1 Expression and Influences Immune Escape in Bladder Cancer.
    Sun A, Luo Y, Xiao W, Zhu Z, Yan H, Miao C, Zhang W, Bai P, Liu C, Yang D, Shao Z, Song J, Wu Z, Chen B, Xing J, Wang T.
    Lab Invest; 2023 Jul 21; 103(7):100148. PubMed ID: 37059268
    [Abstract] [Full Text] [Related]

  • 12. Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis.
    Koll FJ, Banek S, Kluth L, Köllermann J, Bankov K, Chun FK, Wild PJ, Weigert A, Reis H.
    J Transl Med; 2023 Feb 15; 21(1):124. PubMed ID: 36793050
    [Abstract] [Full Text] [Related]

  • 13. Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer.
    Izawa M, Tanaka N, Murakami T, Anno T, Teranishi Y, Takamatsu K, Mikami S, Kakimi K, Imamura T, Matsumoto K, Oya M.
    Lab Invest; 2023 Apr 15; 103(4):100040. PubMed ID: 36870289
    [Abstract] [Full Text] [Related]

  • 14. SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
    Xia QD, Sun JX, Xun Y, Xiao J, Liu CQ, Xu JZ, An Y, Xu MY, Liu Z, Wang SG, Hu J.
    Front Immunol; 2022 Apr 15; 13():864156. PubMed ID: 35418978
    [Abstract] [Full Text] [Related]

  • 15. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
    Guo YZ, Sun HH, Wang XT, Wang MT.
    J Zhejiang Univ Sci B; 2022 Apr 15; 19(9):674-688. PubMed ID: 30178634
    [Abstract] [Full Text] [Related]

  • 16. Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes.
    Liao H, Chen W, Dai Y, Richardson JJ, Guo J, Yuan K, Zeng Y, Xie K.
    Front Oncol; 2019 Apr 15; 9():883. PubMed ID: 31572677
    [Abstract] [Full Text] [Related]

  • 17. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
    Zhang H, Kong W, Zhao X, Han C, Liu T, Li J, Song D.
    BMC Genom Data; 2022 Jan 18; 23(1):8. PubMed ID: 35042477
    [Abstract] [Full Text] [Related]

  • 18. Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
    Xia QD, Sun JX, Liu CQ, Xu JZ, An Y, Xu MY, Liu Z, Hu J, Wang SG.
    Front Cell Dev Biol; 2022 Jan 18; 10():832892. PubMed ID: 35386202
    [Abstract] [Full Text] [Related]

  • 19. Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer.
    Sun M, Zeng H, Jin K, Liu Z, Hu B, Liu C, Yan S, Yu Y, You R, Zhang H, Chang Y, Liu L, Zhu Y, Xu J, Xu L, Wang Z.
    Cancer Immunol Immunother; 2022 Jun 18; 71(6):1497-1506. PubMed ID: 34716763
    [Abstract] [Full Text] [Related]

  • 20. Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
    Yu Y, Zhang W, Li A, Chen Y, Ou Q, He Z, Zhang Y, Liu R, Yao H, Song E.
    JAMA Netw Open; 2020 Apr 01; 3(4):e202149. PubMed ID: 32259264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.